SUNNYVALE, Calif., Dec. 17, 2010 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the company has established a Medical Affairs function to accelerate CyberKnife data collection, utilization and referral patterns and to provide strategic guidance on clinically driven processes, innovations and initiatives.
Since the company's inception in 1990, Accuray has been focused on driving innovation that meets the unique needs of clinicians and patients as part of its corporate strategy to improve patient care across various cancers and indications. With more than 500 peer-reviewed publications supporting the use of CyberKnife radiosurgery, Medical Affairs will continue to further medical research through the development and support of clinical studies and protocols globally, while also strengthening relationships with key opinion leaders and academic centers worldwide.
"We are very proud to announce the formation of Medical Affairs, which demonstrates another positive step in our ongoing strategy toward clinically driven research and development, innovation and customer support," said Euan S. Thomson, Ph.D., president and CEO of Accuray. "Because we are changing clinical practice, we believe this function will play a vital part in supporting our customers in their adoption, utilization and medical research and will be pivotal in helping establish the clinical applications of the future."
Omar Dawood, M.D., M.P.H, a surgeon and radiologist by training who has led Accuray's Clinical Development team over the past three and a half years, will lead the Medical Affairs function, and will report in to Euan Thomson, Accuray's CEO. The organization will focus on understanding the needs of clinicians worldwide and supporting their efforts to advance the field of radiosurgery and improve patient care. </